{
  "outputs": [
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "o3-pro-deep-research",
      "uploadId": "pulmo_tags_test_1_ai_policy",
      "unstructuredTopicList": "1) Artificial Intelligence – AI Model Identifies Potential New Therapy for IPF (June 2025) UNAGI - yale 2)  CHEST and Medical Societies Urge Reversal of Vaccine Panel Shake-up (June 2025)"
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "none",
      "uploadId": "pulmo_tags_test_1_chest",
      "unstructuredTopicList": "1) CHEST Incidence of discordant pleural fluid exudates and diagnostic patterns, 2) CHEST Airway Mucus Plugging in Chronic Bronchitis and the Impact of Bronchial Rheoplasty, 3) CHEST Management of Patients with Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline, 4) CHEST Exercise Doppler Echocardiography of the right heart and pulmonary circulation in patients with cardiovascular risk factors: Observations from the RIGHT Heart International NETwork (RIGHT-NET), 5) CHEST Covert triage during the COVID-19 pandemic: A qualitative analysis of rationing in intensive care, 6) CHEST Post-Treatment Monitoring of Pulmonary Arteriovenous Malformations: Challenges and Approaches, 7) CHEST Deep Learning-Enhanced Non-Invasive Detection of Pulmonary Hypertension and Subtypes via Chest Radiographs, Validated by Catheterization, 8) CHEST Timing of screening benefit for lung cancer with low-dose computed tomography, 9) CHEST Combined Interstitial Features and Emphysema in National Lung Screening Trial Participants: Prognostic Implications, 10) CHEST Comparison of Multiple Strategies to Assess Computed Tomography Lesion Location within the Lung, 11) CHEST Components Necessary for High-Quality Lung Cancer Screening: A 10-Year Update, 12) CHEST Anomalous differences between the Global Lung Function Initiative 2023 and 2012 spirometry reference values, 13) CHEST Delivering a Regional Procedural Boot Camp for Incoming Pulmonary & Critical Care Medicine Fellows, 14) CHEST Excellence for All: Simulation-Based Mastery Learning for ICU Goals of Care Conversations, 15) CHEST TRANSLATING THE MECHANISMS OF HYPOXIA TO LONG-TERM OXYGEN PRESCRIPTION IN COPD: A PROPOSAL, 16) CHEST Pleural fluid analysis: Maximizing diagnostic yield in the pleural effusion evaluation, 17) CHEST Alcohol Use and COVID-19 Outcomes, 18) CHEST Anti-Ro52 Seropositive Interstitial Lung Disease is Associated with a Higher Risk for Disease Progression and Mortality, 19) CHEST The performance of the surrogate informed consent process for critical care research: A multi-modal study of investigators, coordinators, surrogates, and patients, 20) CHEST Hospitalization Trends and Risk Factors in Rheumatoid Arthritis Related Interstitial Lung Disease: An Observational Study from Ontario, Canada, 21) CHEST Longitudinal Pulmonary Arterial Pressure Trajectories Inform Clinical Outcome in Kidney Transplantation Patients, 22) CHEST A Trust That We Work Hard to Maintain, 23) CHEST Pulmonary Rehabilitation Referral Practice Patterns across Lung Transplant Centers in the US: A Multi-Center Survey-Based Study, 24) CHEST Ultrathin bronchoscopy with radial endobronchial ultrasound and rapid on-site evaluation for the diagnosis of peripheral pulmonary lesions: a multicentre randomized controlled factorial trial, 25) CHEST Selecting An Inhaled Delivery System in COPD, 26) CHEST To Make a Self: Exploring and Supporting Professional Identity Formation and Resilience of Intensivists through Humanities, 27) CHEST Tezepelumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following suboptimal response to anti-IL5/5R therapy, 28) CHEST Diagnosing pulmonary embolism during pregnancy: A narrative review, 29) CHEST Sputum Cellularity and MRI Ventilation Defects in Severe Asthma, 30) CHEST Prediction Pathway for Severe Asthma Exacerbations, 31) CHEST How I do it: Best practices for right heart catheterization in the diagnosis of pulmonary hypertension, 32) CHEST Association between a Recalled Positive Airway Pressure (PAP) Device and Obstructive Lung Disease: A Province-Based Study, 33) CHEST Discriminative Accuracy of the Simplified Spirometry for Identifying Spirometry-defined Chronic Obstructive Pulmonary Disease in Community, 34) CHEST Proteomic Analysis of Nasopharyngeal Aspirate Biomarkers for Prematurity-Related Bronchopulmonary Dysplasia, 35) CHEST Health and Utilization Burden of Obstructive Sleep Apnea among U.S. Active-Duty Military Personnel, 36) CHEST Lung Function Decline and Airflow Limitation Risk in Preserved Ratio Impaired Spirometry Subtypes by Smoking Status, 37) CHEST Pregnancy Outcomes in 53 Female Lung Transplant Recipients, 38) CHEST The Impact of Health Care Disparities on Lung Cancer Screening and Treatment, 39) CHEST Evaluating the Nonmalignancy Rate in the National Lung Screening Trial, 40) CHEST Practice Patterns and Patient Travel Distances for Lung Cancer Surgery in the United States, 41) CHEST Defining Interstitial Lung Disease Education in Pulmonary Fellowship, 42) CHEST Lung Cancer Screening Adherence in Centralized vs Decentralized Screening Programs, 43) CHEST Trends in Medicare Spending on Drugs for Pulmonary Arterial Hypertension, 2012-2022, 44) CHEST Oxygen Saturation Targets and Neurologic Outcomes Following Cardiac Arrest, 45) CHEST The frequency and predictors of pulmonary rehabilitation referrals among patients with pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry, 46) CHEST A Prospective, Multicenter Evaluation of Safety and Diagnostic Outcomes With Robotic-Assisted Bronchoscopy, 47) CHEST Postoperative Lung Transplant Considerations in the Older Recipient, 48) CHEST Lung Quantitative CT Scan Textures Are Associated With Systemic Inflammation and Mortality in COPD, 49) CHEST Exercise Hemodynamics and the Evolving Definition of Precapillary Pulmonary Hypertension, 50) CHEST Impact of COVID-19 on Pulmonary Critical Care Fellows In-Training Exam Performance"
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "none",
      "uploadId": "pulmo_tags_test_1_AJRCCM",
      "unstructuredTopicList": "1. AJRCCM Risk Factors for Stress-related UGIB: More than a Gut Feeling, 2) AJRCCM Environmental Sustainability in Intensive Care: From Awareness to Action, 3) AJRCCM On Not Betraying Our Trainees, Especially Now, 4) AJRCCM The Mirage of Individualized Therapy in the United States: Barriers in Pulmonary Hypertension Due to Sickle Cell Disease & Sarcoidosis, 5) AJRCCM A Peek into Pulmonary Hypertension Through the Plasma Proteome, 6) AJRCCM Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome After Hematopoietic Cell Transplantation, 7) AJRCCM DNA Damage in Pulmonary Arterial Hypertension and Veno-occlusive Disease – FANCL as Dual Rescue?, 8) AJRCCM Moving from Observation to Explanation: Probing the Biology of Heterogeneity of Treatment Effects, 9) AJRCCM Reply to Takefuji: Limitations of Linear Dimensional Reduction Methods in COPD Phenotyping, 10) AJRCCM Limitations of Linear Dimensional Reduction Methods in COPD Phenotyping, 11) AJRCCM The Essential Role of Air Quality Monitoring at U.S. Embassies and Consulates, 12) AJRCCM Association of Annual Exposure to Air Pollution Mixture on Asthma Hospitalizations in the U.S., 13) AJRCCM Modeling CF Patient-Specific Responses to CFTR Modulators Using Human Induced Pluripotent Stem Cells, 14) AJRCCM Reply to Hyder et al.: Emergency Intubation—A High-Stakes Procedure with Critical Gaps in Understanding Team Impact, 15) AJRCCM Emergency Intubation—A High-Stakes Procedure with Critical Gaps in Understanding Team Impact, 16) AJRCCM Clinical Remission by a Comprehensive Severe Asthma Management Strategy Guided by Airway Inflammometry and Bioimaging, 17) AJRCCM Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease, 18) AJRCCM Increased Driving Pressure During Assisted Ventilation for Hypoxemic Respiratory Failure Is Associated with Lower ICU Survival: The ICEBERG Study, 19) AJRCCM Is Your Placebo Really Needed?, 20) AJRCCM A New Generation of Clinical Endpoints for Critical Care Trials, 21) AJRCCM Cavitated Pulmonary Nodules: Endemic Kaposi's Sarcoma Recurrence or Another Cause?, 22) AJRCCM A Randomized Controlled Trial of a Post-ICU Telehealth Care Model (WFIT), 23) AJRCCM Bridging the Gap: Small Airways, Mechanical Stress, and the Evolution of Emphysema, 24) AJRCCM Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis, 25) AJRCCM Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis, 26) AJRCCM Reply to Ding et al.: Imatinib: A Promising Therapeutic Shining Light on Pulmonary Arterial Hypertension Treatment, 27) AJRCCM Imatinib: A Promising Therapeutic Shining Light on Pulmonary Arterial Hypertension Treatment, 28) AJRCCM Reply to Wilson et al.: The 4-Month HPMZ Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis – A Word of Caution, 29) AJRCCM The 4-Month HPMZ Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis – A Word of Caution, 30) AJRCCM An Alarming Loss of Pulmonary Rehabilitation Programs: Example from the U.S. Veterans Administration, 31) AJRCCM Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography, 32) AJRCCM Zinc-mediated Inhibition of Soluble Epoxide Hydrolase Promotes Pulmonary Hypertension, 33) AJRCCM Detection and Evaluation of Drug-associated Pulmonary Arterial Hypertension, 34) AJRCCM Metabolomic Evidence of Biological Overlap with HFpEF in a Subset of Pulmonary Arterial Hypertension, 35) AJRCCM Aging Gracefully: Does Elexacaftor/Tezacaftor/Ivacaftor Safety and Efficacy Stand the Test of Time?, 36) AJRCCM Blurred Boundaries: Rethinking Disease Classifications in ILD Using Molecular Signals, 37) AJRCCM Post-COPD: Can Emphysema Be Repaired?, 38) AJRCCM Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3), 39) AJRCCM Refining Pulmonary Embolism Management: Balancing Innovation with Accuracy, 40) AJRCCM Biologic Mechanisms Underlying the Heterogeneous Response to Tight Glycemic Control among Differentially Inflamed Patients in the HALF-PINT Trial, 41) AJRCCM Initial Success: Camlipixant in Refractory Chronic Cough, 42) AJRCCM Reply to Rui and Chen: Initial Success: Camlipixant in Refractory Chronic Cough, 43) AJRCCM Dominant Form of SFTPB: A New Paradigm, 44) AJRCCM Deficient FANCL Predisposes Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension, 45) AJRCCM The Quest for Safe and Effective Bronchoscopic Lung Volume Reduction — A Matter of Correct Scaffolding?, 46) AJRCCM Robotic versus Electromagnetic Bronchoscopy for Peripheral Pulmonary Lesions: A Randomized Trial (RELIANT), 47) AJRCCM Upper Airway Volume Predicts Brain Structure and Cognition in Adolescents, 48) AJRCCM Mucus Plug Density and Type 2 Inflammation in Asthma and/or COPD: Ultra-High-Resolution CT Study, 49) AJRCCM Reply to Zeng: Unveiling the True Cardiovascular Risk in COPD: Is CACS-Tx the Right Approach?, 50) AJRCCM Unveiling the True Cardiovascular Risk in COPD: Is CACS-Tx the Right Approach?, 51) AJRCCM Ansa Cervicalis Stimulation During Non-REM Sleep in a Patient with Obstructive Sleep Apnea, 52) AJRCCM Visualizing Pulmonary Mycobacteriodes abscessus Infections with 11C-PABA PET/CT, 53) AJRCCM Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One F508del Allele"
    },
    {
      "isInSupabase": "false",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "none",
      "uploadId": "pulmo_tags_test_1_lancet",
      "unstructuredTopicList": "1. Lancet Regional Health – Europe Association between income, employment status, and asthma outcomes: a systematic review and meta-analysis, 2) Lancet Respiratory Medicine 2025 GINA report for asthma, 3) Lancet Regional Health – Europe Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022, 4) Lancet Respiratory Medicine Shyamali Dharmage: mapping lung health trajectories across the life course, 5) Lancet Respiratory Medicine Limertinib for EGFR mutation-positive NSCLC treatment, 6) Lancet Respiratory Medicine Is there good evidence of mortality benefits from positive airway pressure?, 7) Lancet Respiratory Medicine First results from the international paediatric bronchiectasis registry (Child-BEAR-Net Registry), 8) Lancet Respiratory Medicine The power of paediatric bronchiectasis health registries, 9) Lancet Eric Donn Bateman, 10) Lancet Respiratory Medicine Why it's more than \"just a cough\", 11) Lancet Respiratory Medicine Medical societies unite against RFK Jr's COVID vaccine update, 12) Lancet Respiratory Medicine Housing is Health Care, 13) Lancet Infectious Diseases Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis, 14) Lancet Respiratory Medicine Onradivir: a novel influenza polymerase inhibitor, 15) Lancet Regional Health – Europe Real-world impact of nirsevimab immunisation against respiratory disease on emergency department attendances and admissions among infants, 16) Lancet Regional Health – Europe Carbon emissions from clinical activities by speciality in secondary and tertiary care in England, 17) Lancet Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte), 18) Lancet Infectious Diseases A new era for respiratory syncytial virus infection control"
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "none",
      "uploadId": "pulmo_tags_test_1_fda",
      "unstructuredTopicList": "1. FDA FDA D.I.S.C.O. Burst Edition: FDA approvals of Tabrecta (capmatinib) for metastatic non-small cell lung cancer and Enhertu (fam-trastuzumab deruxtecan-nxki) for HER2-mutant non-small cell lung cancer, 2) FDA FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer, 3) FDA FDA approves taletrectinib for ROS1-positive non-small cell lung cancer"
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "none",
      "uploadId": "pulmo_tags_test_1_jama",
      "unstructuredTopicList": "1. JAMA Netw Open Intraosseous vs Intravenous Access for Epinephrine in Pediatric Out-of-Hospital Cardiac Arrest, 2) JAMA Surgery Shifting From Thoracic Epidurals to Nerve Blocks—Redefining Gold Standards, 3) JAMA Inhaled Pharmacotherapy for Stable COPD, 4) JAMA Netw Open Prenatal Tobacco and Alcohol Exposure and Cortical Change Among Youths, 5) JAMA Netw Open Ventilatory Support for Cardiac Arrest—One Size May Not Fit All, 6) JAMA Netw Open Bystander CPR Technique and Outcomes for Cardiac Arrest With and Without Opioid Toxicity, 7) JAMA Netw Open Phenotypes of Atopic Dermatitis and Development of Allergic Diseases, 8) JAMA Netw Open Efficiency and Quality of Generative AI–Assisted Radiograph Reporting, 9) JAMA Pediatrics Acceptance and Commitment Therapy–Based Parenting Program in Children With Co-Occurring Asthma and ADHD"
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "o3-deep-research",
      "uploadId": "pulmo_tags_test_1",
      "unstructuredTopicList": "1. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation, 2) Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 Report, 3) US FDA Approves Verona Pharma's Inhaled COPD Therapy, 4) An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline, 5) Inhaled Sedation in Acute Respiratory Distress Syndrome: The SESAR Randomized Clinical Trial, 6) FDA Declines to Approve Gefapixant for Chronic Cough a Second Time, 7) Efficacy and Safety of Pharmacotherapy for Refractory or Unexplained Chronic Cough: A Systematic Review and Network Meta-Analysis"
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "none",
      "uploadId": "pulmo_tags_test_1_bmj",
      "unstructuredTopicList": "1. BMJ Right C7 neurotomy at the intervertebral foramen plus intensive speech and language therapy versus intensive speech and language therapy alone for chronic post-stroke aphasia, 2) BMJ Effect of UK pay-for-performance programme on quality of primary care, 3) BMJ Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors, 4) BMJ Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics, 5) BMJ Oral contraceptives with progestogens and risk of intracranial meningioma, 6) BMJ Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer, 7) BMJ Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis, 8) BMJ P2Y12 inhibitor or aspirin after percutaneous coronary intervention"
    }
  ]
}
